Compare
CBT vs SPY
Up to five stocks or ETFs side by side. Performance is rebased to 100 at the start of the window.
Relative performance
| CBT | SPY | |
|---|---|---|
| Price | $71.05 | $735.29 |
| 1-day | -2.63% | +0.31% |
| YTD | +7.20% | +7.83% |
| 1 year | +17.50% | +8.52% |
| 3 years | +7.29% | +73.97% |
| Market cap | $3.7B | — |
| P/E | 20.0 | — |
| P/S | 1.01 | — |
| P/B | 2.29 | — |
| Revenue growth | -4.70% | — |
| EPS growth | -53.40% | — |
| Gross margin % | 22.7 | — |
| Net margin % | 5.2 | — |
| ROE % | 11.8 | — |
| Debt / equity | 0.68 | — |
| FCF yield % | 7.7 | — |
| Dividend yield % | 2.60 | — |
| Beta | 0.50 | 1.00 |
| RSI (14) | 37.8 | 35.1 |
| Technical rating |